Neurones Stock Beta
NRO Stock | EUR 44.70 0.20 0.45% |
Neurones fundamentals help investors to digest information that contributes to Neurones' financial success or failures. It also enables traders to predict the movement of Neurones Stock. The fundamental analysis module provides a way to measure Neurones' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Neurones stock.
Neurones |
Neurones Company Beta Analysis
Neurones' Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current Neurones Beta | 0.5 |
Most of Neurones' fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Neurones is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
Competition |
In accordance with the recently published financial statements, Neurones has a Beta of 0.5029. This is 52.56% lower than that of the IT Services sector and 59.11% lower than that of the Information Technology industry. The beta for all France stocks is notably lower than that of the firm.
Neurones Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Neurones' direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Neurones could also be used in its relative valuation, which is a method of valuing Neurones by comparing valuation metrics of similar companies.Neurones is currently under evaluation in beta category among related companies.
As returns on the market increase, Neurones' returns are expected to increase less than the market. However, during the bear market, the loss of holding Neurones is expected to be smaller as well.
Neurones Fundamentals
Return On Equity | 0.14 | |||
Return On Asset | 0.077 | |||
Profit Margin | 0.07 % | |||
Operating Margin | 0.11 % | |||
Current Valuation | 735.59 M | |||
Shares Outstanding | 24.22 M | |||
Shares Owned By Insiders | 70.71 % | |||
Shares Owned By Institutions | 15.10 % | |||
Price To Earning | 21.03 X | |||
Price To Book | 3.01 X | |||
Price To Sales | 1.50 X | |||
Revenue | 579.88 M | |||
Gross Profit | 256.58 M | |||
EBITDA | 72.17 M | |||
Net Income | 37.71 M | |||
Cash And Equivalents | 169.6 M | |||
Cash Per Share | 7.20 X | |||
Total Debt | 27.82 M | |||
Debt To Equity | 0.10 % | |||
Current Ratio | 2.53 X | |||
Book Value Per Share | 12.78 X | |||
Cash Flow From Operations | 64.5 M | |||
Earnings Per Share | 1.71 X | |||
Target Price | 47.0 | |||
Number Of Employees | 5.96 K | |||
Beta | 0.5 | |||
Market Capitalization | 1.01 B | |||
Total Asset | 567.82 M | |||
Retained Earnings | 21 M | |||
Working Capital | 151 M | |||
Current Asset | 284 M | |||
Current Liabilities | 133 M | |||
Z Score | 22.6 | |||
Annual Yield | 0.02 % | |||
Five Year Return | 0.30 % | |||
Net Asset | 567.82 M | |||
Last Dividend Paid | 1.0 |
About Neurones Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Neurones's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Neurones using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Neurones based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Neurones in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Neurones' short interest history, or implied volatility extrapolated from Neurones options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neurones. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Complementary Tools for Neurones Stock analysis
When running Neurones' price analysis, check to measure Neurones' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neurones is operating at the current time. Most of Neurones' value examination focuses on studying past and present price action to predict the probability of Neurones' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neurones' price. Additionally, you may evaluate how the addition of Neurones to your portfolios can decrease your overall portfolio volatility.
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Transaction History View history of all your transactions and understand their impact on performance | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |